Cargando…
In vivo delivery of a multiepitope peptide and Nef protein using novel cell-penetrating peptides for development of HIV-1 vaccine candidate
OBJECTIVES: A potent HIV vaccine should overcome some limitations such as polymorphism of human HLA, the diversity of HIV-1 virus, and the lack of an effective delivery system. In this study, a DNA construct encoding Nef(60–84), Nef(126–144), Vpr(34–47), Vpr(60–75), Gp160(30–53), Gp160(308–323,) and...
Autores principales: | Davoodi, Saba, Bolhassani, Azam, Namazi, Fatemeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775797/ https://www.ncbi.nlm.nih.gov/pubmed/33386500 http://dx.doi.org/10.1007/s10529-020-03060-3 |
Ejemplares similares
-
M918: A Novel Cell Penetrating Peptide for Effective Delivery of HIV-1 Nef and Hsp20-Nef Proteins into Eukaryotic Cell Lines
por: Rostami, Bahareh, et al.
Publicado: (2018) -
Immunological investigation of a multiepitope peptide vaccine candidate based on main proteins of SARS-CoV-2 pathogen
por: Khairkhah, Niloofar, et al.
Publicado: (2022) -
Comparison of HIV-1 Vif and Vpu accessory proteins for delivery of polyepitope constructs harboring Nef, Gp160 and P24 using various cell penetrating peptides
por: Kardani, Kimia, et al.
Publicado: (2019) -
Conserved multiepitope vaccine constructs: A potent HIV-1 therapeutic vaccine in clinical trials
por: Akbari, Elahe, et al.
Publicado: (2023) -
Cell penetrating peptide: A potent delivery system in vaccine development
por: Hasannejad-Asl, Behnam, et al.
Publicado: (2022)